VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,169,731 | -46.7% | 154,951 | -40.3% | 0.34% | -42.3% |
| Q2 2023 | $7,818,452 | -6.7% | 259,663 | +0.2% | 0.60% | -9.4% |
| Q1 2023 | $8,379,750 | -13.3% | 259,034 | -23.2% | 0.66% | -13.4% |
| Q4 2022 | $9,669,741 | +2950.4% | 337,395 | +2816.6% | 0.76% | +3075.0% |
| Q2 2022 | $317,000 | 0.0% | 11,568 | +39.8% | 0.02% | +20.0% |
| Q1 2022 | $317,000 | +48.8% | 8,274 | +24.5% | 0.02% | +53.8% |
| Q4 2021 | $213,000 | -83.3% | 6,646 | -82.3% | 0.01% | -84.1% |
| Q2 2021 | $1,272,000 | +56.7% | 37,448 | +49.9% | 0.08% | +36.7% |
| Q1 2021 | $812,000 | +24.0% | 24,981 | +37.4% | 0.06% | +22.4% |
| Q4 2020 | $655,000 | +89.9% | 18,179 | +106.6% | 0.05% | +69.0% |
| Q3 2020 | $345,000 | +35.3% | 8,800 | +1.1% | 0.03% | +16.0% |
| Q4 2019 | $255,000 | +9.9% | 8,700 | 0.0% | 0.02% | +4.2% |
| Q3 2019 | $232,000 | – | 8,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |